Aims It is unclear whether the future risk of cardiovascular events in breast cancer (Bc)
survivors is greater than in the general population. This meta-analysis quantifies the risk of …

PURPOSE To examine cardiovascular disease (CVD) and mortality risk in women with
breast cancer (BC) by cancer therapy received relative to women without BC. METHODS …

Abstract Purpose of Review Cardiovascular disease is long-term complication of both
cancer and anti-cancer treatment and can have significant ramifications for health-related …

Background: Breast cancer survivors treated with anthracycline-based chemotherapy (AC)
have increased risk of functional limitation and cardiac dysfunction. We conducted a 12 …

Background Cancer survivors have a higher risk for developing cardiovascular diseases
than the general population. Objectives The aim of this study was to investigate whether …

Background Cardiovascular disease (CVD) is the leading cause of death worldwide. The
aim of this study was to examine if CVD affects the mortality of women after a breast cancer …

Background Breast cancer is the most commonly diagnosed cancer in women worldwide,
and underlying mechanistic pathways associated with breast cancer-specific and non-breast …

Purpose Heart disease is a significant concern among breast cancer survivors, in part due to
cardiotoxic treatments including chemotherapy and radiotherapy. Long-term trends in heart …

Background Breast cancer is a chronic disease with a large growth in its treatments,
prognosis, improvements, side effects and rehabilitation therapies research. These …

Introduction The increasing survival of patients with breast cancer has prompted the
assessment of mortality due to all causes of death in these patients. We estimated the …